Showing 281 - 300 results of 102,658 for search '(( 12 mg decrease ) OR ( 5 ((((we decrease) OR (a decrease))) OR (greater decrease)) ))', query time: 1.58s Refine Results
  1. 281
  2. 282
  3. 283

    Antineoplastic Effects of siRNA against TMPRSS2-ERG Junction Oncogene in Prostate Cancer by Giorgia Urbinati (554921)

    Published 2015
    “…Two of the five siRNAs tested were found to efficiently inhibit mRNA of both <i>TMPRSS2-ERG</i> variants and to decrease ERG protein expression. …”
  4. 284
  5. 285
  6. 286

    A Functional 12T-Insertion Polymorphism in the <i>ATP1A1</i> Promoter Confers Decreased Susceptibility to Hypertension in a Male Sardinian Population by Victoria L. Herrera (383897)

    Published 2015
    “…To test the effects of decreased α1Na,K-ATPase expression on blood pressure, we measured blood pressure by radiotelemetry in three month-old, highly inbred heterozygous knockout <i>ATP1A1+/−</i> male mice with resultant 58% reduction in ATP1A1 protein levels. …”
  7. 287
  8. 288
  9. 289
  10. 290
  11. 291

    TGFβ1 expression was increased, and RASAL1 expression was decreased in NTM cells in response to a hypoxic environment. by Fiona McDonnell (2636635)

    Published 2016
    “…A 0hr Control was set to 100%, and the normoxic and hypoxic results were presented as a percentage of this; Normoxic = 95.5%, Hypoxic = 159.4% (P<0.01). n = 3 *P<0.05, **P<0.01. …”
  12. 292
  13. 293
  14. 294
  15. 295

    Activated CD8 T cells in FOXO3−/− mice display decreased apoptosis. by Jeremy A. Sullivan (183868)

    Published 2012
    “…<p>To address whether the increase in antigen-specific cells observed in FOXO3−/− mice at day 8 was in fact the result of decreased apoptosis, we assessed the relative expression levels of a number of cell survival or cell death markers. …”
  16. 296
  17. 297

    The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin... by Chanel Avenant (409756)

    Published 2025
    “…The open-label WHICH clinical trial, conducted at two sites in South Africa from 2018–2019, randomized HIV-negative women aged 18–40 years to 150 mg DMPA-IM 12-weekly (n = 262) or 200 mg NET-EN 8-weekly (n = 259). …”
  18. 298
  19. 299
  20. 300